Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Orphazyme A/S (CO: ORPHA)

 
ORPHA Technical Analysis
4
As on 12th Nov 2024 ORPHA STOCK Price closed @ 940.10 and we RECOMMEND Buy for LONG-TERM with Stoploss of 493.46 & Strong Buy for SHORT-TERM with Stoploss of 1.66 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ORPHASTOCK Price

Open 940.10 Change Price %
High 940.10 1 Day 0.00 0.00
Low 940.10 1 Week -59.90 -5.99
Close 940.10 1 Month 42.10 4.69
Volume 4 1 Year 937.84 41497.35
52 Week High 1400.00 | 52 Week Low 0.74
 
CO Denmark Most Active Stocks
SAS 0.01 0.00%
NOVO-B 444.30 3.59%
VWS 98.66 6.09%
CONFRZ 0.02 0.00%
BAVA 164.70 6.19%
GN 91.20 2.96%
VJBA 4.60 2.45%
GREENH 0.22 0.00%
ALMB 15.50 -1.02%
ASTRLS 1.15 8.49%
 
CO Denmark Top Gainers Stocks
HYDRCT 0.60 46.34%
SHAPE 14.98 23.60%
HYPE 3.66 22.00%
DKIEEU 249.00 15.81%
NEXCOM 4.78 11.16%
SAME 1.45 10.69%
SAME 1.45 10.69%
SOLAR-B 298.00 8.96%
CHEMM 490.00 8.89%
ASTRLS 1.15 8.49%
 
CO Denmark Top Losers Stocks
VALUER 0.25 -21.88%
BLVIS-A 0.40 -18.37%
HAPPY 0.18 -10.00%
NEWCAP 0.09 -10.00%
SCAPE 0.11 -8.33%
NKT 509.00 -7.54%
NKT 509.00 -7.54%
NKT 509.00 -7.54%
NKT 509.00 -7.54%
NKT 509.00 -7.54%
 
 
ORPHA
Daily Charts		 ORPHA
Intraday Charts		 Whats New @
Bazaartrend		 ORPHA
Free Analysis
 
ORPHA Important Levels Intraday
RESISTANCE940.10
RESISTANCE940.10
RESISTANCE940.10
RESISTANCE940.10
RESISTANCE940.10
RESISTANCE940.10
RESISTANCE940.10
RESISTANCE940.10
 
ORPHA Forecast May 2025
Share
4th UP Forecast941.83
3rd UP Forecast941.28
2nd UP Forecast940.93
1st UP Forecast940.59
1st DOWN Forecast939.61
2nd DOWN Forecast939.27
3rd DOWN Forecast938.92
4th DOWN Forecast938.37
 
ORPHA Weekly Forecast
4th UP Forecast942.70
3rd UP Forecast941.87
2nd UP Forecast941.35
1st UP Forecast940.84
1st DOWN Forecast939.36
2nd DOWN Forecast938.85
3rd DOWN Forecast938.33
4th DOWN Forecast937.50
 
ORPHA Forecast2025
4th UP Forecast3877.35
3rd UP Forecast2935.36
2nd UP Forecast2353.09
1st UP Forecast1770.82
1st DOWN Forecast109.38
2nd DOWN Forecast-472.89
3rd DOWN Forecast-1055.16
4th DOWN Forecast-1997.15
 
 
ORPHA Other Details
Segment EQ
Market Capital 908757184.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ORPHA Address
ORPHA
 
ORPHA Latest News
 
Your Comments and Response on Orphazyme A/S
 
ORPHA Business Profile
Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative orphan diseases. The company focuses on the amplification of heat-shock proteins to develop and commercialize therapeutics for diseases caused by protein misfolding and aggregation, and lysosomal dysfunction, including lysosomal storage and neuromuscular degenerative diseases. Its lead candidate is the Arimoclomol, which is in clinical development for four orphan diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, Inclusion Body Myositis, and Gaucher disease. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark. Address: Ole MaalOees Vej 3, Copenhagen, Denmark, 2200
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service